MPNs

Latest News

Scott Evaluates Treatment Options for Hydroxyurea-Resistant Polycythemia Vera
Scott Evaluates Treatment Options for Hydroxyurea-Resistant Polycythemia Vera

March 28th 2024

In a Community Case Forum event in partnership with the Washington State Medical Oncology Society, Bart Scott, MD, broke down various trials of hydroxyurea, ruxolitinib, and interferon in patients with polycythemia vera to assess outcomes such as hematocrit control and molecular response.

Navigating Emerging Therapies in Myelofibrosis Treatment
Navigating Emerging Therapies in Myelofibrosis Treatment

March 25th 2024

Weighing the Triggers for Initiating JAK2 Inhibition Therapy in MF
Weighing the Triggers for Initiating JAK2 Inhibition Therapy in MF

March 23rd 2024

Participants Discuss Treating a Patient With Myelofibrosis and Anemia
Participants Discuss Treating a Patient With Myelofibrosis and Anemia

March 18th 2024

FDA ODAC Votes Yes on Imetelstat for Patients with MDS
FDA ODAC Votes Yes on Imetelstat for Patients with MDS

March 14th 2024

Video Series
Video Interviews

More News